Dr Reddys Laboratories (RDY) Minority Interest (2013 - 2026)
Dr Reddys Laboratories (RDY) posted Minority Interest of $34.9 million for Q2 2026, down 5.92% on a QoQ basis from $37.1 million in Q1 2026, and down 19.12% year-over-year from $43.2 million in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Minority Interest (2013 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Minority Interest for 4 years, with the latest figure at $34.9 million in Q2 2026.
- On a quarterly basis, Minority Interest fell 19.12% year-over-year to $34.9 million in Q2 2026; TTM through Jun 2026 was $34.9 million, a 19.12% decrease from a year earlier, with the FY2026 full-year figure at $36.0 million, down 18.18% from the prior year.
- Minority Interest was $34.9 million for Q2 2026 at Dr Reddys Laboratories, down from $37.1 million in the prior quarter.
- The five-year high for Minority Interest was $47.0 million in Q3 2024, with the low at $34.9 million in Q2 2026.
- Average Minority Interest over 3 years is $41.3 million, with a median of $42.2 million recorded in 2025.
- The sharpest annual moves came in 2025 and 2026: Minority Interest decreased 12.41% in 2025, then fell 19.12% in 2026.
- Over 3 years, Minority Interest stood at $45.5 million in 2024, then dropped by 16.38% to $38.1 million in 2025, then declined by 8.24% to $34.9 million in 2026.
- The last three Minority Interest figures came in at $34.9 million (Q2 2026), $37.1 million (Q1 2026), and $38.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.93 Mn |
| Mar 31, 2026 | 37.13 Mn |
| Dec 31, 2025 | 38.07 Mn |
| Sep 30, 2025 | 41.19 Mn |
| Jun 30, 2025 | 43.19 Mn |
| Mar 31, 2025 | 43.63 Mn |
| Dec 31, 2024 | 45.53 Mn |
| Sep 30, 2024 | 47.03 Mn |
| Mar 31, 2013 | 354,342.45 |